Related Experiment Video

Updated: Aug 24, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.3K

Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson's Disease by

Wusheng Lu1, Jinhuang Lin1, Dequan Zheng1

  • 1Department of Neurology, The 909th Hospital of (People's Liberation Army) PLA, Zhangzhou, Fujian, China (mainland).

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|October 26, 2022
PubMed

Insights

This study on Parkinson's disease models is retracted due to duplicated figure content, raising concerns about the research integrity and findings related to microRNA-133a and RAC1.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms.
  • Apoptosis and autophagy are critical cellular processes implicated in PD pathogenesis.
  • MicroRNAs (miRNAs) play regulatory roles in cellular functions and disease development.

Purpose of the Study:

  • To investigate the role of microRNA-133a (miR-133a) in a cell model of Parkinson's disease.
  • To examine the effects of miR-133a on apoptosis and autophagy.
  • To determine the downstream targets of miR-133a, specifically Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1).

Main Methods:

  • Establishment of a cell model mimicking Parkinson's disease conditions.
  • Overexpression of microRNA-133a in the cell model.
  • Assessment of apoptosis and autophagy markers.
  • Analysis of RAC1 expression levels.

Main Results:

  • Overexpression of microRNA-133a was found to inhibit apoptosis and autophagy in the Parkinson's disease cell model.
  • MicroRNA-133a was shown to downregulate the expression of Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1).

Conclusions:

  • MicroRNA-133a may act as a protective factor by inhibiting apoptosis and autophagy in Parkinson's disease.
  • The downregulation of RAC1 by microRNA-133a is a potential mechanism underlying its effects.
  • Further research is needed to validate these findings and explore therapeutic potential.

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.7K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
352
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K